Evogene (EVGN) CDO Gabi Tarcic Buys 1,129 Shares

What Happened Gabi Tarcic, Chief Development Officer of Evogene Ltd. (EVGN), acquired 1,129 shares in an open-market purchase on 2026-06-04 at $0.60 per share, for a total cash outlay of about $677. This transaction was a purchase (insider acquisition), not a sale.

Key Details

• Transaction date: 2026-06-04
• Transaction type/code: Open-market purchase (P)
• Price per share: $0.60; Shares purchased: 1,129; Total value: ~$677
• Form filed with SEC: filed 2026-08-26 (the filing is later than the typical two-business-day Form 4 deadline)
• Shares owned after transaction: Not specified in the provided excerpt
• Footnotes:
  • F1: Related options vest over four years (25% at first anniversary of 11/20/2024, then 6.25% quarterly) — full vesting on 11/20/2028.
  • F2: Indicates no transactions in the securities referenced in that row; holdings provided for informational purposes only.
• Remark: Exhibit 24.1 is a Power of Attorney.

Context The trade is a small open-market purchase by an executive; purchases are often of particular interest to investors because they represent insider acquisitions, but filings should be evaluated along with overall holdings and company news. The late filing reduces the timeliness of this disclosure for investors; late Form 4s are commonly corrected but can attract regulatory notice depending on circumstances.